Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. by Campa, D, Pastore, M, Gentiluomo, M, Talar-Wojnarowska, R, Kupcinskas, J, Malecka-Panas, E, Neoptolemos, J, Niesen, W, Vodicka, P, Delle Fave, G, Bas Bueno-de-Mesquita, H, Gazouli, M, Pacetti, P, Di Leo, M, Ito, H, Klüter, H, Soucek, P, Corbo, V, Yamao, K, Hosono, S, Kaaks, R, Vashist, Y, Gioffreda, D, Strobel, O, Shimizu, Y, Dijk, F, Andriulli, A, Ivanauskas, A, Bugert, P, Tavano, F, Vodickova, L, Federico Zambon, C, Lovecek, M, Landi, S, Key, T, Boggi, U, Pezzilli, R, Jamroziak, K, Mohelnikova-Duchonova, B, Mambrini, A, Bambi, F, Busch, O, Pazienza, V, Valente, R, Theodoropoulos, G, Hackert, T, Capurso, G, Martina Cavestro, G, Pasquali, C, Basso, D, Sperti, C, Matsuo, K, Büchler, M, Khaw, K, Izbicki, J, Costello, E, Katzke, V, Michalski, C, Stepien, A, Rizzato, C, Canzian, F